Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 12-2011 | 06-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 48,490 | 64,910 | 42,660 |
| Receivables | 13,510 | 8,870 | 5,830 |
| Other current assets | 10 | 0 | 10 |
| TOTAL | $62,010 | $73,780 | $48,500 |
| Non-Current Assets | |||
| Investments And Advances | 860 | 960 | 1,430 |
| Other Non-Current Assets | 8,850 | 8,970 | 0 |
| TOTAL | $9,710 | $9,930 | $1,430 |
| Total Assets | $71,730 | $83,710 | $59,680 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 21,100 | 18,410 | 8,340 |
| Other current liabilities | N/A | 0 | 10 |
| TOTAL | $22,750 | $21,580 | $11,340 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 12,270 | 18,790 | 500 |
| TOTAL | $17,290 | $25,050 | $7,770 |
| Total Liabilities | $40,050 | $46,630 | $19,120 |
| Shareholders' Equity | |||
| Common Shares | 2,420 | 2,620 | 2,710 |
| Retained earnings | -110,360 | -116,560 | -110,290 |
| Other shareholders' equity | 190 | -30 | -7,560 |
| TOTAL | $31,670 | $37,080 | $40,550 |
| Total Liabilities And Equity | $71,720 | $83,710 | $59,670 |